What medications are used to treat mastitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mastitis Medication

For lactational mastitis in breastfeeding women, first-line antibiotic therapy is dicloxacillin 500 mg orally four times daily or cephalexin 500 mg orally four times daily, targeting Staphylococcus aureus, which causes the majority of infectious mastitis cases. 1

When to Start Antibiotics

  • Begin with a 1-2 day trial of conservative measures first (NSAIDs, ice application, direct breastfeeding, minimizing pumping) before initiating antibiotics, as most mastitis cases are inflammatory rather than truly infectious 2
  • Start antibiotics if symptoms do not improve within 24-48 hours of conservative management 2
  • Initiate antibiotics immediately if the patient appears systemically ill with high fever or signs of sepsis 2

First-Line Antibiotic Options

Preferred Agents

  • Dicloxacillin 500 mg orally four times daily is the oral agent of choice for methicillin-susceptible S. aureus 1, 3
  • Cephalexin 500 mg orally four times daily is an equally effective alternative, particularly useful for penicillin-allergic patients 1
  • Both agents are safe during breastfeeding with minimal transfer to breast milk 1, 4
  • Dicloxacillin has a relative infant dose of only 0.03%, well below the 10% threshold of concern 4

Alternative Antibiotics

  • Amoxicillin/clavulanic acid is a broad-spectrum option safe during breastfeeding based on limited human data 1
  • Clindamycin should be considered for suspected or confirmed MRSA, though use with caution as it may increase gastrointestinal side effects in the infant 1
  • Erythromycin or azithromycin are acceptable for penicillin-allergic patients, but carry a very low risk of infantile hypertrophic pyloric stenosis if used during the first 13 days of infant life 1

MRSA Coverage Considerations

  • Consider MRSA coverage if local MRSA prevalence is high, patient has previous MRSA infection, or there is no response to first-line therapy 1
  • As methicillin-resistant S. aureus becomes more common, antibiotics effective against this organism may become preferred first-line agents 5

Duration and Monitoring

  • Reevaluate within 48-72 hours if symptoms worsen or do not improve after starting antibiotics to rule out abscess formation 1
  • Obtain milk cultures to guide antibiotic therapy, especially in cases not responding to initial treatment 2
  • Consider alternative antibiotics based on culture results 1

Critical Management Principles

  • Continue breastfeeding during antibiotic treatment - this does not pose risk to the infant and helps resolve the mastitis 1, 5
  • Encourage frequent, complete emptying of the breast through direct breastfeeding rather than pumping 5, 2
  • Breast abscess occurs in approximately 10% of mastitis cases and can be prevented by early antibiotic treatment and continued breastfeeding 1, 5

Common Pitfalls to Avoid

  • Do not recommend excessive pumping, heat application, or aggressive breast massage - these practices overstimulate milk production and cause tissue trauma, potentially worsening the condition 2
  • Do not delay antibiotic therapy beyond 48 hours if conservative measures fail 2
  • Do not discontinue breastfeeding from the affected breast during treatment 5, 3
  • Probiotics for treatment or prevention are not supported by good evidence 2

Inpatient Management

  • Hospital admission with intravenous antibiotics is required if the condition worsens or there is concern for sepsis 2
  • Perform ultrasonography to identify abscesses in immunocompromised patients or those with worsening or recurrent symptoms 2

References

Guideline

First-Line Antibiotics for Mastitis in Breastfeeding Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mastitis: Rapid Evidence Review.

American family physician, 2024

Research

[Treatment of mastitis in general practice].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2003

Research

Transfer of Dicloxacillin into Human Milk.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2020

Research

Management of mastitis in breastfeeding women.

American family physician, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.